Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Depreciation & Amortization (CF) (2023 - 2025)

Upstream Bio (UPB) has 3 years of Depreciation & Amortization (CF) data on record, last reported at $46000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 228.57% year-over-year to $46000.0; the TTM value through Sep 2025 reached $180000.0, up 233.33%, while the annual FY2024 figure was $89000.0, 48.33% up from the prior year.
  • Depreciation & Amortization (CF) reached $46000.0 in Q3 2025 per UPB's latest filing, up from $42000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $49000.0 in Q4 2024 and bottomed at $13000.0 in Q1 2024.
  • Average Depreciation & Amortization (CF) over 3 years is $29250.0, with a median of $28000.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 250.0% in 2024, then soared 223.08% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $14000.0 in 2023, then surged by 250.0% to $49000.0 in 2024, then dropped by 6.12% to $46000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $46000.0 in Q3 2025, $42000.0 in Q2 2025, and $43000.0 in Q1 2025.